Showing results (51-60 of 157) with videos related to
Sort By:
Pageof 16
Progress in Neuro-Psychopharmacology & Biological Psychiatry|June 3, 2000
Clozapine and negative symptoms. An open studyP M Llorca, C Lancon, J Farisse, et al.Acta Psychiatrica Scandinavica|November 20, 2025
Association Between Metabolic Syndrome, Obesity, and Cognitive Performances in Individuals With Bipolar Disorders: Cross-Sectional and Longitudinal Analyses in the FACE-BD CohortI Palimaru, B Etain, M Leboyer, et al.International Journal of Clinical Pharmacology and Therapeutics|January 26, 2008
Long-term remission in schizophrenia and related psychoses with long-acting risperidone: results obtained in an open-label study with an observation period of 18 monthsP-M Llorca, E Sacchetti, K Lloyd, et al.Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|September 28, 2020
Épidémiologie descriptive du risque suicidaire dans le système médical français de médecine généraleJ-L Ducher, P-M Llorca, S Callahan, et al.L'Encephale|May 4, 2020
[Challenges for psychotropics in the context of the SARS-Cov-2 pandemic]H Javelot, P-M Llorca, G Meyer, et al.L'Encephale|February 11, 2000
[The concept of supersensitivity psychosis. The particular case of clozapine]P M Llorca, F Penault, C Lançon, et al.Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|December 10, 1999
An exploration of the psychometric properties of the French version of the Positive and Negative Syndrome ScaleC Lançon, V Aghababian, P M Llorca, et al.Journal of Affective Disorders|March 27, 2022
Key findings on bipolar disorders from the longitudinal FondaMental Advanced Center of Expertise-Bipolar Disorder (FACE-BD) cohortM Leboyer, O Godin, P M Llorca, et al.L'Encephale|August 16, 2022
[Evaluation of the effectiveness of a cognitive remediation program in anorexia nervosa using new neuropsychological tools: A case study]S Pires, M Villemeyre-Plane, S Berthoz, et al.Pageof 16